Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

22nd Century Group Inc XXII

Consumer Defensive Tobacco
22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.


NDAQ:XXII - Post by User

22nd Century Group Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(263)
•••
Post by whytestockson Sep 06, 2024 1:45pm
49 Views
Post# 36212140

22nd Century Group to Participate in the HC Wainwright Confe

22nd Century Group to Participate in the HC Wainwright Confe
NEWS: $XXII 22nd Century Group to Participate in the HC Wainwright Conference on September 10, 2024Mocksville, North Carolina--(Newsfile Corp. - September 6, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company leading the fight against nicotine with its 95% less nicotine brand VLN&#xAE; focused on nicotine harm reduction and contract manufacturing, today announced that...XXII - 22nd Century Group to Participate in the HC Wainwright Conference on September 10, 2024

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities